China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

OraSure Technologies reported after the close of the market Wednesday that its fourth quarter 2021 revenues increased 1 percent year over year.

Agilent Technologies reported after the close of the market on Tuesday that its fiscal first quarter revenues rose 8 percent year over year.

Bio-Techne said on Tuesday that it has inked a development and license agreement with Thermo Fisher Scientific to complete development of and commercialize Bio-Techne's ExoTru kidney transplant rejection test, a multigene urine-based assay.

On February 23, Lepu Biopharma Co., Ltd. was listed on Hong Kong Exchanges and Clearing Limited (HKEX), stock code: 2157.HK. The issue price is HKD 7.13 per share, and public offering raised about HKD 900 million.

Recently, Shenzhen Third People's Hospital/The Second Affiliated Hospital of Southern University of Science and Technology and Roche Diagnostics formally reached a strategic cooperation to jointly establish the "Roche Strategic Cooperation Hospital".

Hypoxia-triggered platinum supernanoparticles dissociated into ultrasmall platinum nanoclusters, which could be cleared by the kidney through urine, in response to the tumor microenvironment.

Illumina and Beckman Coulter Life Sciences said on Tuesday that they have partnered on application development for the Biomek NGenius next-generation library preparation system.

On the evening of February 18, Shenzhen YHLO Biotech Co., Ltd. announced that it received a purchase order from the Institute of Medical Biology Co., Ltd.. According to the purchase order, MBL will purchase antigen test kits from the YHLO, the total amount is approximately CNY 316 million.

British testing firm DnaNudge announced on Wednesday that it has partnered with Pantonic Health to launch its CovidNudge test in Australia.

Diagnostics manufacturer Quidel reported after the close of the market on Thursday that its fourth quarter revenues fell more than 21 percent year over year due primarily to shift in product mix and decreased COVID-19 product sales.